| Time | Session |
|---|
|
10:45
20:00
|
Novel Antibody Therapeutics: Anti-BCMA.ECD for Personalised Cell Therapy in Multiple Myeloma
P-448
EACR25-0072
Gunjan Dagar
Poster Presenter
India
|
DLL3-targeting CAR-T cells enhanced by co-deletion of PD1 exhibit better efficacy and persistence in a pre-clinical animal model for small cell lung cancer
P-449
EACR25-0102
Hua Zhang
Poster Presenter
Hong Kong, China
|
Fishing for new immunotherapy compounds to boost innate-tumor rejection
P-450
EACR25-0448
Ana Beatriz Machado
Poster Presenter
Portugal
|
Preclinical double humanized CD47/SIRPα mouse model and MC38 cell line expressing human CD47 for efficacy and safety assessment of anti-CD47/SIRPΑ-targeting therapies
P-451
EACR25-0518
Fabiane Sonego
Poster Presenter
France
|
Development of the in vitro 3D Spheroid High-Throughput Screening Platform for the Development of Immune Checkpoint Inhibitors
P-452
EACR25-0586
Michal Rudnik
Poster Presenter
Switzerland
|
Integrating the Fasting-Mimicking Diet to Augment Anti-tumor Immunity following Adoptive Cell Transfer in Breast Cancer.
P-453
EACR25-0656
Evangelia Pavlou
Poster Presenter
Italy
|
ROR1-Specific CAR T-Cells: Advancing Targeted Immunotherapy for Cancer
P-454
EACR25-0710
Adrian-Bogdan Tigu
Poster Presenter
Romania
|
Improved Adoptive T Cell Therapies for Colorectal Liver Metastases by Stabilization of IFNAR1 on Tumor-Specific T-Cells
P-455
EACR25-0726
Andrea Castiglioni
Poster Presenter
Italy
|
A Pro-Tumorigenic Cytokine with an Unexpected Anti-Cancer Role: TGFβ Enhances NK cell Immunotherapy for pancreatic cancer
P-456
EACR25-0738
Valenzano Giampiero
Poster Presenter
United Kingdom
|
Development of a humanized anti-ANXA3 monoclonal antibody for potential treatment of hepatocellular carcinoma
P-457
EACR25-0752
IANTO BOSHENG HUANG
Poster Presenter
Hong Kong, China
|
Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy
P-458
EACR25-0974
Andrea Lad
Poster Presenter
Hungary
|
Novel Harnessing of Innate and Adaptive Anti-Cancer Immunity: NLRP3-Inflammasome Activation Facilitates Immune Checkpoint Blockade in the Treatment of Mesenchymal Stage IV Colorectal Cancer
P-459
EACR25-1026
Klimpe Luis
Poster Presenter
Germany
|
Immunopeptidomics approach for the identification of neoantigens in multiple myeloma
P-460
EACR25-1028
Gabriela Anna Zuleger
Poster Presenter
Germany
|
Bridging the Gap Between In Vitro and In Vivo: STC-1010 Cancer Vaccine Efficacy in 3D Tumor Spheroids
P-461
EACR25-1044
George Alzeeb
Poster Presenter
France
|
CAM Assay: An Alternative, 3Rs-compliant, In Vivo Model for the Development of Anticancer Immunotherapies
P-462
EACR25-1120
Yan Wang
Poster Presenter
France
|
Targeting UMG1, a highly glycosylated cancer specific CD43 epitope, by a Bispecific T-Cell Engager (BTCE) in Malignant Melanoma
P-463
EACR25-1140
EMANUELA ALTOMARE
Poster Presenter
Italy
|
Exploiting human ALK.CAR-T cell therapy for the treatment of ALK+ small cell lung cancer
P-464
EACR25-1142
Monkca Maccagno
Poster Presenter
Italy
|
Redirecting cytomegalovirus immunity against pancreas cancer for immunotherapy
P-465
EACR25-1156
Tatiana Hurtado de Mendoza
Poster Presenter
United States
|
Comparative analysis of neoadjuvant PD1+Lenvatinib versus PD1 alone in the tumour immune microenvironment of melanoma: Correlation of immune profiling with pathological response.
P-466
EACR25-1196
Jordan William Conway
Poster Presenter
Australia
|
Optimized Timing of CD25-Biased IL-2/JES6 (IL-2/IL-2 mAb Complex) Administration Enhances Antitumor Efficacy of Immune Checkpoint Inhibitors
P-466A
EACR25-1240
Irfan Baki K
Poster Presenter
Czech Republic
|
CD25-Biased IL-2/Anti-IL-2 Complexes Enhance Antigen-Primed CD8⁺ T Cell Expansion, Overcome Treg-Mediated Suppression, and Exhibit Significant Antitumor Activity
P-467
EACR25-1288
Petra Weberova
Poster Presenter
Czech Republic
|
RALA-PRAME DNA Vaccine: A Novel Immunotherapy for High-Grade Serous Ovarian Carcinoma
P-468
EACR25-1428
Chayanika Saha
Poster Presenter
United Kingdom
|
Accelerating the Manufacture of γδ T Cells for Allogeneic Cancer Therapies: Integrated Cell Differentiation and Expansion in Bioreactors
P-470
EACR25-1528
Miguel de Almeida Fuzeta
Poster Presenter
Portugal
|
Blockade of PD-L1 endocytosis by uPAR antagonist peptides to improve cancer immunotherapy
P-471
EACR25-1544
Elena Frediani
Poster Presenter
Italy
|
Impact of Immune Checkpoint Inhibitors on Recurrence Patterns in Early-Stage NSCLC
P-471A
EACR25-1554
Sofia Silva
Poster Presenter
Spain
|
Targeting solid tumor cell lines of diverse histological origins with nucleolin-specific CAR-T cells - a proof-of-concept
P-472
EACR25-1684
Teresa Raquel Abreu
Poster Presenter
Portugal
|
Immunization against a mutant p53-derived neoantigen by a personalized oncolytic adenovirus
P-473
EACR25-1700
Fred Bunz
Poster Presenter
United States
|
IL17A depletion remodels pancreatic tumor matrix and boosts ENO1 vaccine efficacy
P-474
EACR25-1822
Giorgia Tiberi
Poster Presenter
Italy
|
Generation of versatile tumor target cell lines using the SpyCatcher/SpyTag system
P-475
EACR25-1904
Filipa Moraes
Poster Presenter
Portugal
|
Development of a faster potency assay for evaluation of immune cell-mediated cytotoxicity in vitro
P-484A
EACR25-1960
Zhong Yu
Poster Presenter
|
CAPTN-3: A novel platform of conditionally activated T cell and NK cell engagers
P-476
EACR25-1964
Hadas Reuveni
Poster Presenter
Israel
|
Detecting changes in the tumour microenvironment and in CAR T infiltration following chemotherapeutic priming using intravital imaging
P-477
EACR25-2022
Marija Dinevska
Poster Presenter
Australia
|
Novel NK Cell Immunotherapy Strategy to Enhance Tumor Killing and Overcome Microenvironment Resistance
P-478
EACR25-2174
Paola Vacca
Poster Presenter
Italy
|
Neutrophil serine proteases alter IL-18 to a superkine
P-479
EACR25-2188
Anne W
Poster Presenter
Sweden
|
Unlocking the Potential of Dendritic Cell-Derived Extracellular Vesicles in Targeting Triple-Negative Breast Cancer
P-915
EACR25-2224
Sofia Torres Quintas
Poster Presenter
Portugal
|
Boosting Melanoma Immunotherapy: Synergizing Nanovaccines with PD-L1 Modulation
P-480
EACR25-2430
Margarida Ferreira-Silva
Poster Presenter
Portugal
|
Anti-CD19 therapy (Blinatumomab®) as a bridge therapy for hematopoietic stem cell transplantation in pediatric patients with relapsed/refractory B-type acute lymphoblastic leukemia Ph-negative
P-481
EACR25-2510
Talita Fernandes Nunes
Poster Presenter
Brazil
|
NK Cell Exhaustion in Multiple Myeloma: Pathways to Novel Immunotherapies
P-482
EACR25-2554
Jacopo Umberto Verga
Poster Presenter
Ireland
|
Accelerating immuno-oncology research with flexible workflows using modular Flex-Fit CyTOF panels
P-483
EACR25-2558
Melissa Klug
Poster Presenter
|
RAS(ON) G12C-selective and multi-selective doublet combination overcomes clinical resistance mechanisms to KRAS G12C(OFF) inhibitors and sensitizes to immune checkpoint blockade in preclinical models
P-484
EACR25-2588
Cristina Blaj
Poster Presenter
United States
|